Prospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Pathophysiol. May 22, 2021; 12(3): 51-58
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.51
Table 1 Patient characteristics and frequency of cytomegalovirus reactivation before liver transplantation

Total (%)
Reactivation (%)
RR (95%CI)
P value
Number of patients (%)72 (100)23 (32)
Gender (male)21 (29.2)7 (33.3)1.09 (0.37-3.23)0.871
Mean age, years (SD)56.3 (9.6)57.3 (9.2)NA0.900
MELD, median (IqR)12 (14)12 (12)NA0.712
Lymphocyte count, median (IqR)929 (808)929 (770)NA0.471
CMV receptor IgG-negative5 (8.7)2 (40)0.68 (0.11-4.40)0.652
HCV46 (63.9)15 (32.6)1.09 (0.39-3.1)0.872
HBV5 (6.9)1 (20)0.51 (0.05-4.9)1.000
Hepatocarcinoma42 (58.3)14 (33.3)1.17 (0.42-3.2)0.765
Fulminant hepatitis2 (3)0NANA
Diabetes mellitus24 (33.3)8 (33.3)1.1 (0.38-3.13)0.858
Renal failure8 (11.1)5 (62.5)4.26 (0.92-19.7)0.100
Re-transplant2 (3)0NANA